asia pacific medical device security market

Asia Pacific Medical Device Security Market 2021-2031 by Component (Solutions, Services), Security Type (Endpoint Security, Network Security, Cloud Security, Application Security), Device Type (Stationery, Embedded, Wearable), Deployment Mode (On-premise, Cloud-based), End User (Healthcare Providers, Medical Device Manufacturers, Others), and Country: Trend Forecast and Growth Opportunity

  • Published Date: 2022-04-20
  • Report ID: 128493
  • Pages: 116
  • Format: prudent report format

Asia Pacific medical device security market will grow by 13.1% annually with a total addressable market cap of $39,022.1 million over 2022-2031, driven by the growing demand for connected medical devices due to the aging population and the growth in chronic disease management, the widespread adoption of digital solutions for patient data collection and storage, the increasing instances of cyber-attacks and threats in the healthcare industry, advancing technologies such as IoT/cloud/AI, and the government regulations and need for compliance.
Highlighted with 31 tables and 58 figures, this 116-page report Asia Pacific Medical Device Security Market 2021-2031 by Component (Solutions, Services), Security Type (Endpoint Security, Network Security, Cloud Security, Application Security), Device Type (Stationery, Embedded, Wearable), Deployment Mode (On-premise, Cloud-based), End User (Healthcare Providers, Medical Device Manufacturers, Others), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific medical device security market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific medical device security market in every aspect of the classification from perspectives of Component, Security, Device Type, Deployment Mode, End User, and Country.

Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Solutions
o Identity & Access Management (IAM)
o Intrusion Detection System/Intrusion Prevention System (IDS/IPS)
o Encryption
o Disaster Recovery
o Distributed Denial of Service (DDoS)
o Antivirus & Antimalware
o Data Loss Prevention (DLP)
o Risk and Compliance Management
o Other Solutions
Services
o Implementation & Integration Service
o Consulting & Training Service
o Support & Maintenance service

Based on Security, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Endpoint Security
Network Security
Cloud Security
Application Security
Other Security Types

By Device Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Stationery Medical Devices
Internally Embedded Medical Devices
Wearable and External Medical Devices

By Deployment Mode, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
On-premise Medical Device Security
Cloud-based Medical Device Security

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Healthcare Providers
Medical Device Manufacturers
Other End Users

Geographically, the following national/local markets are fully investigated:
Japan
China
South Korea
Australia
India
Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Security Type and Device Type over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
CA Technologies, Inc.
Check Point Software Technologies Ltd.
Cisco Systems, Inc.
ClearDATA
DXC Technology
FireEye (Symphony Technology Group)
Fortinet Inc.
GE Healthcare
IBM Corporation
Koninklijke Philips N.V.
McAfee, LLC
Palo Alto Networks
Sophos Ltd.
Symantec Corporation
Zscaler, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)


1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porters Fiver Forces Analysis 39
3 Segmentation of Global Market by Offering 43
3.1 Market Overview by Offering 43
3.2 Services 45
3.3 Test Kits & Consumables 46
4 Segmentation of Global Market by Application 47
4.1 Market Overview by Application 47
4.2 Non-Hodgkins Lymphoma (NHL) 49
4.2.1 DLBCL 51
4.2.2 Marginal Zone Lymphoma 52
4.2.3 Follicular Lymphoma 53
4.2.4 Peripheral T-cell Lymphoma 54
4.2.5 Mantle Cell Lymphoma 55
4.2.6 Other NHLs 56
4.3 Multiple Myeloma (MM) 57
4.4 Acute Lymphoblastic Leukemia (ALL) 58
4.5 Chronic Lymphoblastic Leukemia (CLL) 59
4.6 Acute Myeloid Leukemia (AML) 60
4.7 Chronic Myeloid Leukemia (CML) 61
4.8 Hodgkins Lymphoma (HL) 62
4.9 Solid Tumor 63
4.10 Other Applications 64
5 Segmentation of Global Market by Technology 65
5.1 Market Overview by Technology 65
5.2 Flow Cytometry 67
5.3 Polymerase Chain Reaction (PCR) 68
5.4 Next-Generation Sequencing (NGS) 69
5.5 Other Technologies 70
6 Segmentation of Global Market by End User 71
6.1 Market Overview by End User 71
6.2 Hospitals and Clinics 73
6.3 Research Institutions 74
6.4 Diagnostic Laboratories 75
6.5 Other End Users 76
7 Segmentation of Global Market by Region 77
7.1 Geographic Market Overview 2021-2031 77
7.2 North America Market 2021-2031 by Country 81
7.2.1 Overview of North America Market 81
7.2.2 U.S. 85
7.2.3 Canada 88
7.2.4 Mexico 90
7.3 European Market 2021-2031 by Country 92
7.3.1 Overview of European Market 92
7.3.2 Germany 96
7.3.3 U.K. 98
7.3.4 France 100
7.3.5 Spain 102
7.3.6 Italy 104
7.3.7 Netherlands 106
7.3.8 Rest of European Market 108
7.4 Asia-Pacific Market 2021-2031 by Country 110
7.4.1 Overview of Asia-Pacific Market 110
7.4.2 Japan 114
7.4.3 China 117
7.4.4 Australia 119
7.4.5 India 121
7.4.6 South Korea 123
7.4.7 Rest of APAC Region 125
7.5 South America Market 2021-2031 by Country 127
7.5.1 Argentina 130
7.5.2 Brazil 132
7.5.3 Chile 134
7.5.4 Rest of South America Market 136
7.6 MEA Market 2021-2031 by Country 137
7.6.1 UAE 140
7.6.2 Saudi Arabia 142
7.6.3 South Africa 144
7.6.4 Other National Markets 146
8 Competitive Landscape 147
8.1 Overview of Key Vendors 147
8.2 New Product Launch, Partnership, Investment, and M&A 151
8.3 Company Profiles 152
Adaptive Biotechnologies Corporation 152
ArcherDX, Inc. (Invitae Corporation) 154
Arup Laboratories 155
Asuragen Inc. 156
Bio-Rad Laboratories, Inc. 157
Cergentis B.V. 158
Guardant Health 159
ICON plc 160
Inivata Ltd. 161
Invivoscribe, Inc. 162
Laboratory Corporation of America Holdings 163
Mission Bio, Inc. 164
Natera, Inc. 165
NeoGenomics Laboratories, Inc. 166
Opko Health, Inc. 167
Quest Diagnostics Incorporated 168
Sysmex Corporation 169
RELATED REPORTS 170
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.